American College of Obstetrics and Gynecology
July 2010
Mark Schiffman, MD, MPH, and Nicolas Wentzensen, MD, PhD
Cervical cancer is one of the most common female
malignancies worldwide; 80% of cases occur in
low-resource regions.1,2 Screening programs have been
very successful in the United States, Europe, and other
regions able to achieve broad and sustained coverage. In
the United States, the disease is controlled at an annual
cost of billions of dollars representing a major commitment
by patients and clinicians.
